KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Prepaid Assets: 2009-2024

Historic Prepaid Assets for Idexx Laboratories (IDXX) over the last 16 years, with Dec 2024 value amounting to $256.2 million.

  • Idexx Laboratories' Prepaid Assets rose 38.56% to $310.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $310.4 million, marking a year-over-year increase of 38.56%. This contributed to the annual value of $256.2 million for FY2024, which is 25.83% up from last year.
  • As of FY2024, Idexx Laboratories' Prepaid Assets stood at $256.2 million, which was up 25.83% from $203.6 million recorded in FY2023.
  • Idexx Laboratories' Prepaid Assets' 5-year high stood at $256.2 million during FY2024, with a 5-year trough of $137.5 million in FY2020.
  • In the last 3 years, Idexx Laboratories' Prepaid Assets had a median value of $220.5 million in 2022 and averaged $226.8 million.
  • In the last 5 years, Idexx Laboratories' Prepaid Assets grew by 26.85% in 2022 and then decreased by 7.66% in 2023.
  • Over the past 5 years, Idexx Laboratories' Prepaid Assets (Yearly) stood at $137.5 million in 2020, then rose by 26.41% to $173.8 million in 2021, then grew by 26.85% to $220.5 million in 2022, then fell by 7.66% to $203.6 million in 2023, then grew by 25.83% to $256.2 million in 2024.